Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Sweden / NCT02802618
Active, not recruiting Not applicable

Interactive 3D Visualization Technique Used in Pulmonary Rehabilitation Programme in COPD

NCT02802618 · tracked via the Priya Life Science Sweden tracker
Sponsor
Karolinska University Hospital
Phase
Not applicable
Started
2013-10
Last updated
2025-03-06

Condition(s) studied

Chronic Obstructive Pulmonary Disease

Investigational drug(s) / intervention(s)

Interactive 3D visualization technique

Interactive 3D visualization technique: The pulmonary rehabilitation consists of exercise training during two times/week for 10 weeks and a theoretic part presented with 3D visualization technique.

Study summary

A new education material with 3D technique was developed, by integrating 3D technology in an existing evidence-based pulmonary educational program, to enable an increased personalized education within a group setting. The investigators believe that this educational model will lead to increased adherence to treatment, and suggested lifestyle changes, which in turn improves patients' HRQL

The purpose of this study was therefore to develop a pulmonary educational program in interactive 3D visualization technology and to evaluate differences between education with 3D technique or conventional technique in patient with COPD.

Furthermore the LCQ will be translated and culturally adapted into Swedish and tested for validity and reliability.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Clinical diagnosis of chronic obstructive pulmonary disease (COPD) * Stadium II-IV of COPD * Must be able to comprehend the Swedish language Exclusion Criteria: * Not diagnosed with COPD * Does not understand written and verbal Swedish

Primary outcome measure(s)

  • Improved health related quality of life — Change from Baseline health related quality of life at 10 weeks
    COPD Assessment Test

Trial sites (1)

FacilityCityRegionStatus
Department of physiotherapy, Karolinska University Hospital Stockholm Sweden

More Karolinska University Hospital trials in Sweden

Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer Recruiting
Follow-up of Cell Changes in the Cervix Active, not recruiting
Catheter Ablation vs Conservative Care in Elderly Patients With Atrial Fibrillation Recruiting
National Register Studies in Thoracic Surgery Active, not recruiting
Instructed Home-based Physical Exercise for Patients With Liver Cirrhosis Recruiting

Other trials for the same condition

An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study Enrolling by invitation
Vowel Segmentation for Classification of Chronic Obstructive Pulmonary Disease Using Machine Learning Active, not recruiting
BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study Active, not recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype Recruiting
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease. Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02802618 on ClinicalTrials.gov ↗ ← All trials in Sweden